145 related articles for article (PubMed ID: 3513529)
1. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
Keenan RE; Black PL; Freudenburg JC; Hill JA; Holmburg CE; Reitbrock MJ; Sullivan MJ; Thompson MT; Wright DL
Am J Cardiol; 1986 Mar; 57(9):38E-42E. PubMed ID: 3513529
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
[TBL] [Abstract][Full Text] [Related]
3. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
[TBL] [Abstract][Full Text] [Related]
4. Clonidine and guanfacine in hypertension.
Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
Rosenthal JH
Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
[TBL] [Abstract][Full Text] [Related]
6. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
7. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluations of therapeutic efficacy and safety of guanfacine.
Jerie P
Am J Cardiol; 1986 Mar; 57(9):55E-59E. PubMed ID: 3513532
[TBL] [Abstract][Full Text] [Related]
9. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
11. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
12. An ambulatory trial of guanfacine.
Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
[TBL] [Abstract][Full Text] [Related]
13. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
16. Effects of single and multiple doses of guanfacine in essential hypertension.
Zamboulis C; Reid JL
Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
[TBL] [Abstract][Full Text] [Related]
17. Guanfacine as monotherapy for systemic hypertension.
Fillingim JM; Blackshear JL; Strauss A; Strauss M
Am J Cardiol; 1986 Mar; 57(9):50E-54E. PubMed ID: 3513531
[TBL] [Abstract][Full Text] [Related]
18. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
19. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
20. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
Dupont AG; Vanderniepen P; Six RO
Br J Clin Pharmacol; 1987 Apr; 23(4):397-401. PubMed ID: 3555578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
